Nike forecasts surprise sales drop as China weakness hurts turnaround efforts

Nike shares fell more than 9% in extended trading after management warned of a surprise drop in current-quarter sales, projecting a 2%–4% decline versus Wall Street's +1.9% consensus. Q3 revenue was flat at $11.28B (vs $11.24B est) and EPS beat at $0.35 (vs $0.28 est), but China sales fell 10% and are expected to drop ~20% in Q4; gross margin contracted 130 bps to 40.2% and the company expects to finish Q4 with excess inventory.

Analysis

Nike’s weakness creates a durable opportunity for Chinese incumbents to convert short-term share shifts into structural gains: local brands run faster product cycles, lower unit economics on key SKUs, and tighter distribution relationships that can accelerate wallet-share transfer in tier-1/2 cities. Suppliers and logistics partners will re-optimize capacity toward higher-volume domestic names, meaning the supply base could become a persistent tailwind for ANTA/Li Ning even after Nike stabilizes.

Inventory overhang and a move away from aggressive promotions are likely to push Nike toward two non-linear outcomes: a prolonged period of promotional price pressure that compresses industry gross margins, or a tighter assortment strategy that sacrifices near-term top-line for margin recovery. Key catalysts to watch are sequential inventory declines, wholesale sell-through improvements, and a visible cadence of new product launches — each would alter the trajectory on a 3–9 month horizon; macro shocks (oil, tariffs, China policy) remain shorter-term volatility drivers.

The market may be pricing more permanent damage than warranted in the U.S. channel while underestimating how quickly domestic Chinese competitors can monetize share gains. That creates asymmetric trades: a tactical short into momentum if sales/inventory signals worsen over the next 1–3 months, paired with a selective long exposure to well-capitalized Chinese brands for a 6–18 month re-rating if they continue to gain distribution and premiumize product tiers.

Key Decisions for Investors

• Pair trade (3–12 months): Short NKE equity vs Long ANTA (dollar-neutral). Rationale: short-term downside on Nike from inventory/marketing reset, upside for ANTA from faster product cadence and domestic share gains. Position sizing: short $1 of NKE for every $1 of ANTA long; stop-loss if pair underperforms by 10% (pair basis). Target asymmetric return: 20–40% relative outperformance for ANTA vs NKE.
• Options hedge/spec (1–6 months): Buy a 6-month NKE put spread (buy near-ATM put / sell ~15–20% OTM put) to limit premium spend while capturing downside from a delayed turnaround or promotional escalation. Risk/reward: limited cost (max loss = premium), potential 3x+ payoff if NKE gaps lower >15% over the period. Enter if 30-day IV exceeds 6-month IV by >10% to collect term premium.
• Event-driven long (6–18 months): Initiate a starter position in ANTA (or call spread if preferred) on any meaningful pullback, targeting a 30–50% upside if domestic premiumization and channel expansion continue. Risk: China macro/policy shocks and FX; use 20–30% position scaling with add-on on confirmation of sequential share gains.
• Portfolio defense (1–3 months): Reduce concentrated consumer discretionary exposure and buy short-dated puts on NKE or XLY as tail protection around upcoming retail datapoints (monthly retail sales, China PMI). This hedges a cluster risk where inventory destocking triggers broader discretionary multiple compression; accept 1–2% P&L insurance cost to cap downside in a liquidity-stressed sell-off.